自引率: 6.3%
被引量: 6460
通过率: 暂无数据
审稿周期: 2.31
版面费用: 暂无数据
国人发稿量: 267
投稿须知/期刊简介:
Journal of Cancer is an open access, peer-reviewed journal with broad scope covering all areas of cancer research, especially novel concepts, new methods, new regimens, new therapeutic agents, and alternative approaches for early detection and intervention of cancer. The Journal is supported by an international editorial board consisting of a distinguished team of cancer researchers. Journal of Cancer aims at rapid publication of high quality results in cancer research while maintaining rigorous peer-review process.Types of articles:Research paperShort research communicationReviewHypothesisMethod and protocolNew instruments and regimensLetter to the editor Publication ChargesPublished articles of Journal of Cancer are open access and full texts appear in PubMed Central. This effectively removes the barriers for timely distribution of the articles and ensures that they can be read by as many as possible. Payment can be made by credit card or bank transfer. Instruction for payment is sent during publication process and is also available in the manuscript login page as soon as manuscript is accepted. Publication fee is required to cover the cost of publication, and should be paid before copyediting and publication.Research paper/<br>Review/<br>Short research communication/<br>Others$AUD 2000Letter$AUD 1000* $AUD: Australian dollar
期刊描述简介:
Journal of Cancer is an open access, peer-reviewed journal with broad scope covering all areas of cancer research, especially novel concepts, new methods, new regimens, new therapeutic agents, and alternative approaches for early detection and intervention of cancer. The Journal is supported by an international editorial board consisting of a distinguished team of cancer researchers. Journal of Cancer aims at rapid publication of high quality results in cancer research while maintaining rigorous peer-review process. Types of articles: Research paper Short research communication Review Hypothesis Method and protocol New instruments and regimens Letter to the editor Publication Charges Published articles of Journal of Cancer are open access and full texts appear in PubMed Central. This effectively removes the barriers for timely distribution of the articles and ensures that they can be read by as many as possible. Payment can be made by credit card or bank transfer. Instruction for payment is sent during publication process and is also available in the manuscript login page as soon as manuscript is accepted. Publication fee is required to cover the cost of publication, and should be paid before copyediting and publication.
-
The cellular signaling crosstalk between memory B cells and tumor cells in nasopharyngeal carcinoma cannot be overlooked: Their involvement in tumor progression and treatment strategy is significant.
Background: Nasopharyngeal carcinoma (NPC) refers to a cancerous tumor that develops in the upper and side walls of the nasopharyngeal cavity. Typically, individuals are often diagnosed with the disease when it has already progressed significantly, and those with advanced NPC tend to have an unfavorable outlook in terms of response rate to targeted treatments and overall clinical survival. Various molecular mechanisms, including Myeloid-derived suppressor cells and factors like PD-L1, have been explored to enhance the outcome of NPC. However, there are still challenges to be addressed in terms of identifying symptoms at an early stage, making precise predictions about the chances of cancer returning and spreading, and devising successful approaches for treatment. The activation of B cells and their corresponding pathways holds potential for developing enhanced immune therapeutic strategies. Nevertheless, the comprehensive understanding of the intricate association between B cells and NPC tumor cells remains incomplete. Hence, this study employed single-cell multi-omics analysis to investigate the molecular biomarkers and prognostic factors linked to B cell subpopulations in human NPC while examining the underlying mechanisms. Materials and Methods: The Gene Expression Omnibus database provided tumor and blood samples obtained from patients diagnosed with NPC. Subsequently, we analyzed these single-cell data. Following the assessment of NPC sample quality, we employed the R package 'Harmony' to mitigate batch discrepancies using PCA outcomes. The analysis of Gene Ontology, Gene Set Enrichment Analysis, and Kyoto Encyclopedia of Genes and Genomes was used to examine differentially expressed genes in B cell subpopulations of NPC tumors. The pseudo-temporal trajectories of B cells in NPC were studied using the Monocle and Slingshot software tools. In addition, the CellChat package was utilized to predict the incidence of intercellular communication between different subpopulations of B cells and cancerous cells. Furthermore, we utilized univariate Cox regression, LASSO, and multivariate Cox regression analysis to construct prognostic models. The immune cell infiltration was evaluated in tumor tissues using ESTIMATE, CIBERSORT, and xCell. Furthermore, the infercnv was employed to assess the extent of copy number variation in NPC cells. To forecast the potential reaction of particular tumor samples to chemotherapy, the R package called 'pRRophetic' was utilized. Results: Single-cell RNA sequencing effectively identified various cell subgroups in NPC, including T/NK cells, B cells, plasma cells, myeloid cells, mast cells, and malignant cells. A comprehensive examination of the B cell subgroups revealed their division into 13 distinct groups, each with unique characteristics and functions. Enrichment analysis indicated that C4 CD86+ Memory B cells may play a role in inhibiting viral invasion and activity. Through trajectory analysis, we mapped the differentiation pathways of B cells and found that C4 CD86+ Memory B cells represent the final stage of this differentiation process. Furthermore, signal communication analysis revealed that C4 CD86+ Memory B cells have the potential to initiate interactions with malignant cells via the CD99-CD99, SEMA4-PLXNB2, and notably the CD46-JAG1 signaling pathways. To construct the CD86+ Memory B score, we employed univariate Cox regression analysis, LASSO regression analysis, and multivariate Cox regression analysis to screen 14 genes based on the top 100 marker genes of C4 CD86+ Memory B cells. Conclusion: The results indicate that the C4 CD86+ Memory B cells may have a suppressive impact on viral activity in NPC. However, patients with a higher subgroup of CD86+Memory B scores exhibited a worse prognosis. This could be attributed to the crucial involvement of C4 CD86+ Memory B cells in the proliferation and differentiation of tumor cells, which occurs through the CD46-JAG1 signaling pathway. The discoveries provide significant insights into the fundamental mechanisms of developing NPC. Moreover, these factors greatly influence the prognosis of individuals suffering from this specific type of cancer and offer crucial perspectives for the advancement of future treatment approaches.
被引量：- 发表：1970
-
A Novel Tumor-Associated Neutrophil-Related Risk Signature Based on Single-Cell and Bulk RNA-Sequencing Analyses Predicts the Prognosis and Immune Landscape of Breast Cancer.
被引量：- 发表：1970
-
SCAMP1 silencing inhibits proliferation by attenuating multiple pro-survival signaling pathways in gastric cancer.
被引量：- 发表：1970
-
PD-1 Inhibitors Combined with Chemotherapy versus Re-irradiation/chemoradiotherapy for Unresectable Locally Recurrent T3-4 Nasopharyngeal Carcinoma: A Retrospective Study.
被引量：- 发表：1970
-
Lactate Metabolism Subtypes Analysis Reveals CCDC80 as a Novel Prognostic Biomarker in Gastric Cancer.
被引量：- 发表：1970
